The increased expression of SIGLEC1 is closely related to tumor formation and metastasis [18,19,20], and the increased expression of ICOS leads to poor prognosis and significantly increased PDCD1 expression in ovarian tumors [21,22,23]. Here, SIGLEC1 is linked to neoplasm.